SavedAdd your journal

Journals / Yüksek İhtisas Üniversitesi Sağlık Bilimleri Dergisi / 2026 / Cilt: 7 Sayı: 2

Acetaminophen and Its Potential Anticancer Effects in NSCLC via Serotonin-Mediated Cellular Mechanisms

Küçük Hücreli Dışı Akciğer Kanserinde Asetaminofen’in Serotonin Aracılı Hücresel Mekanizmalar Yoluyla Potansiyel Antikanser Etkileri

Ayşegül Akbay(YÜKSEK İHTİSAS ÜNİVERSİTESİ)0009-0003-6793-4887
Rabia Şeyma Nur Taşdemir(YÜKSEK İHTİSAS ÜNİVERSİTESİ, LİSANSÜSTÜ EĞİTİM ENSTİTÜSÜ)0000-0003-1364-3614
Pages
79–82
Publication Date
2026-08-28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This commentary article explores the hypothesis that acetaminophen may exert an anticancer effect in Non- small cell lung cancer cells through serotonin-related mechanisms, discussing potential molecular interactions, signaling pathways, and therapeutic implications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This commentary article explores the hypothesis that acetaminophen may exert an anticancer effect in Non- small cell lung cancer cells through serotonin-related mechanisms, discussing potential molecular interactions, signaling pathways, and therapeutic implications.
📊
Key Findings & Data:This commentary article explores the hypothesis that acetaminophen may exert an anticancer effect in Non- small cell lung cancer cells through serotonin-related mechanisms, discussing potential molecular interactions, signaling pathways, and therapeutic implications.
💡
Conclusion & Impact:This commentary article explores the hypothesis that acetaminophen may exert an anticancer effect in Non- small cell lung cancer cells through serotonin-related mechanisms, discussing potential molecular interactions, signaling pathways, and therapeutic implications.
🔬Design:Görüş Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Kanser · küçük hücreli dışı akciğer kanseri · asetaminofen

Abstract

This commentary article explores the hypothesis that acetaminophen may exert an anticancer effect in Non- small cell lung cancer cells through serotonin-related mechanisms, discussing potential molecular interactions, signaling pathways, and therapeutic implications.

Özet

Bu yorum makalesinde, asetaminofen’in serotonin ile ilişkili mekanizmalar yoluyla küçük hücreli dışı akciğer kanseri hücrelerinde antikanser etki gösterebileceği hipotezi araştırılmakta, olası moleküler etkileşimler, sinyal yolları ve terapötik etkiler tartışılmaktadır.

🔖

Cite This Article

Akbay, A., Taşdemir, R. Ş. N. (2026). Acetaminophen and Its Potential Anticancer Effects in NSCLC via Serotonin-Mediated Cellular Mechanisms. Yüksek İhtisas Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 7 Sayı: 2, 79–82. https://ajindex.com/articles/1647669

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Sorin M, Prosty C, Ghaleb L, Nie K, Katergi K, Shahzad MH, Dubé LR, Atallah A, Swaby A, Dankner M, Crump T, Walsh LA, Fiset PO, Sepesi B, Forde PM, Cascone T, Provencio M, Spicer JD. Neoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-Analysis. JAMA Oncol 2024;10(5):621–633. https://doi.org/10.1001/jamaoncol.2024.0057
  2. Wu J, Maller B, Kaul R, Galabow A, Bryan A, Neuwelt A. High-Dose Acetaminophen as a Treatment for Cancer. Livers 2024;4:84–93. https://doi. org/10.3390/livers4010007
  3. Irinmwinuwa NEO, Unekwe NPC, Egba NEU, Metu NEC, Cherech NNC. Acetaminophen: Ancient drug with a novel analgesic mechanism of action. WJARR 2022;16(1):580–589. https://doi.org/10.30574/wjarr.2022.16.1.1046
  4. Chen L, Huang S, Wu X, He W, Song M. Serotonin signalling in cancer: Emerging mechanisms and therapeutic opportunities. Clin Transl Med. 2024 Jul;14(7):e1750. https://doi.org/10.1002/ctm2.1750
  5. Mao L, Xin F, Ren J, Xu S, Huang H, Zha X, Wen X, Gu G, Yang G, Cheng Y, Zhang C, Wang W, Liu X. 5-HT2B-mediated serotonin activation in enterocytes suppresses colitis-associated cancer initiation and promotes cancer progression. Theranostics 2022;12(8):3928–3945. https://doi.org/10.7150/ thno.70762
  6. Karmakar S, Lal G. Role of serotonin receptor signaling in cancer cells and anti-tumor immunity. Theranostics 2021;11(11):5296–5312. https://doi. org/10.7150/thno.55986
  7. Al-kuraishy HM, Al-Gareeb A, Albuhadily A, Abdelmaksoud E, Alexiou A, Papadakis M, Batiha G. The efficacy and safety of Acetaminophen for pain relief. Authorea. 2024. https://doi.org/10.22541/au.171361353.33776062/v1
  8. Bunsick DA, Matsukubo J, Aldbai R, Baghaie L, Szewczuk MR. Functional Selectivity of Cannabinoid Type 1 G Protein-Coupled Receptor Agonists in Transactivating Glycosylated Receptors on Cancer Cells to Induce Epithelial– Mesenchymal Transition Metastatic Phenotype. Cells 2024;13(6):480. https:// doi.org/10.3390/cells13060480
  9. Pickering G, Loriot MA, Libert F, Eschalier A, Beaune P, Dubray C. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. Clinical Pharmacology & Therapeutics 2006;79(4):371-378
  10. Hamurtekin Y, Nouilati A, Demirbatir C, Hamurtekin E. The Contribution of Serotonergic Receptors and Nitric Oxide Systems in the Analgesic Effect of Acetaminophen: An Overview of the Last Decade. Turk J Pharm Sci 2020;17(1):119-126. https://doi.org/10.4274/tjps.galenos.2018.35403
  11. Lee JS, Park SY, Kim NY, Kim DW, Oh JE, Heo E, Lee JS, Yoo YC. AntiTumor Potential of a 5-HT3 Receptor Antagonist as a Novel Autophagy Inducer in Lung Cancer: A Retrospective Clinical Study with In Vitro Confirmation. J Clin Med. 2019 Sep 3;8(9):1380. https://doi.org/10.3390/jcm8091380
  12. Yoo YC, Lin L, Lee S, Shin YR, Oh JE, Kim NY. Palonosetron, a 5-HT3 Receptor Antagonist, Induces G1 Cell Cycle Arrest and Autophagy in Gastric Cancer Cells. Int J Mol Sci. 2025 Oct 15;26(20):10039. https://doi.org/10.3390/ ijms262010039
  13. Ataee R, Ajdary S, Rezayat M, Shokrgozar MA, Shahriari S, Zarrindast MR. Study of 5HT3 and HT4 receptor expression in HT29 cell line and human colon adenocarcinoma tissues. Arch Iran Med. 2010 Mar;13(2):120-5
  14. Serafeim A, Holder MJ, Grafton G, Chamba A, Drayson MT, Luong QT, Bunce CM, Gregory CD, Barnes NM, Gordon J. Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells. Blood. 2003 Apr 15;101(8):3212-9. https://doi.org/10.1182/blood-2002-07-2044
  15. Duarte D, Vale N. Antidepressant Drug Sertraline against Human Cancer Cells. Biomolecules. 2022 Oct 19;12(10):1513. https://doi.org/10.3390/ biom12101513. PMID: 36291722; PMCID: PMC9599050
  16. Ballou Y, Rivas A, Belmont A, Patel L, Amaya CN, Lipson S, Khayou T, Dickerson EB, Nahleh Z, Bryan BA. 5-HT serotonin receptors modulate mitogenic signaling and impact tumor cell viability. Mol Clin Oncol. 2018 Sep;9(3):243-254. https://doi.org/10.3892/mco.2018.1681
  17. Gai C, Yu M, Li Z, Wang Y, Ding D, Zheng J, Lv S, Zhang W, Li W. Acetaminophen sensitizing erastin-induced ferroptosis via modulation of Nrf2/ heme oxygenase-1 signaling pathway in non-small-cell lung cancer. J Cell Physiol. 2020 Apr;235(4):3329-3339. https://doi.org/10.1002/jcp.29221. Epub 2019 Sep 20. PMID: 31541463
  18. Du X, Wang T, Wang Z, Wu X, Gu Y, Huang Q, Wang J, Xie J. 5-HT7 Receptor Contributes to Proliferation, Migration and Invasion in NSCLC Cells. Onco Targets Ther. 2020 Mar 9;13:2139-2151. https://doi.org/10.2147/OTT. S244339